Univera Inc Seattle, WA - 98121

Univera Inc is categorized under Wholesale Pharmaceutical Products in Seattle, WA and active since 1998.

Univera Inc was established in 1998, and today employs 1 to 4, earning $20.000.000 to $49.9999.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 5416130 by the NAICS.

If you are seeking more information, feel free to contact Bill Lee, Chief Executive Officer at the company’s single location by writing to 3005 1st Avenue, Seattle, Washington WA 98121 or by phoning (360) 486-7500. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Univera Inc
Contact Person: Bill Lee, Chief Executive Officer
Address: 3005 1st Avenue, Seattle, Washington 98121
Phone Number: (360) 486-7500
Website Address: univera.com
Annual Revenue (USD): $20.000.000 to $49.9999.999
Founded: 1998
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Wholesale Pharmaceutical Products
SIC Code: 5122
NAICS Code: 5416130
Share This Business:

Univera Inc was started in 1998 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 5416130. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $20.000.000 to $49.9999.999 per annum.

Feel free to contact Bill Lee, Chief Executive Officer for inquiries that concern Univera Inc by calling the company number (360) 486-7500, as your correspondence is most welcome. Additionally, the physical location of the single location of Univera Inc can be found at the coordinates 47.617688,-122.354069 as well as the street address 3005 1st Avenue in Seattle, Washington 98121.

For its online presence, you may visit Univera Inc’s website at univera.com and engage with its social media outlets through on Twitter and on Facebook.